Testicular cancer
A Study Testing Two Medicines (Erlotinib and Everolimus) for People With Advanced Chordoma That Is Getting Worse
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Dr. BRA IRCH, All India Institute of Medical Sciences, New DelhiNew Delhi, DelhiDirections ↗
Registry summary (technical)
ECHO-EVE: A Phase II Single Arm Study Evaluating the Efficacy and Safety of Erlotinib with Everolimus in Patients with Symptomatic or Progressive Advanced or Metastatic Chordoma - ECHO-EVE
Sponsor: Dr BRA Institute Rotary Cancer Hospital IRCH All India Institute of Medical Sciences AIIMS
CTRI/2026/03/106129 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 27 Apr 2026 · read by us 5 Nov 2026